Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 17, 2018
The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series
Michelle C Nguyen, Manisha H Shah, David A Liebner, et al.
JCO Precision Oncology
|
September 14, 2020
Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens
Margaret A Hay, Eric A Severson, Vincent A Miller, et al.
BMC Cancer
|
June 7, 2020
Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis
Dionisia Quiroga, David A Liebner, Jennifer S Philippon, et al.
JAMA Network Open
|
October 3, 2019
Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma
Nathan D Seligson, Achal Awasthi, Sherri Z Millis, et al.
Annals of Surgical Oncology
|
June 17, 2023
Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study
Luke V Selby, Emma C Clark, David A Liebner, et al.
Ophthalmic Genetics
|
February 18, 2015
Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients
Colleen M Cebulla, Elaine M Binkley, Robert Pilarski, et al.
Melanoma Research
|
January 11, 2014
Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib
David A Liebner, Steven A Walston, Robert Cavaliere, et al.
Journal of Surgical Oncology
|
May 31, 2016
Patterns of major wound complications following multidisciplinary therapy for lower extremity soft tissue sarcoma
Eric D Miller, Xiaokui Mo, Nicole T Andonian, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2024
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses
Nathan D Seligson, James L Chen, Austin C Goodrich, et al.
The Oncologist
|
July 24, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study
Richard F Riedel, Karla V Ballman, Yao Lu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 17, 2018
The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series
Michelle C Nguyen, Manisha H Shah, David A Liebner, et al.
JCO Precision Oncology
|
September 14, 2020
Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens
Margaret A Hay, Eric A Severson, Vincent A Miller, et al.
BMC Cancer
|
June 7, 2020
Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis
Dionisia Quiroga, David A Liebner, Jennifer S Philippon, et al.
JAMA Network Open
|
October 3, 2019
Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma
Nathan D Seligson, Achal Awasthi, Sherri Z Millis, et al.
Annals of Surgical Oncology
|
June 17, 2023
Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study
Luke V Selby, Emma C Clark, David A Liebner, et al.
Ophthalmic Genetics
|
February 18, 2015
Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients
Colleen M Cebulla, Elaine M Binkley, Robert Pilarski, et al.
Melanoma Research
|
January 11, 2014
Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib
David A Liebner, Steven A Walston, Robert Cavaliere, et al.
Journal of Surgical Oncology
|
May 31, 2016
Patterns of major wound complications following multidisciplinary therapy for lower extremity soft tissue sarcoma
Eric D Miller, Xiaokui Mo, Nicole T Andonian, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2024
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses
Nathan D Seligson, James L Chen, Austin C Goodrich, et al.
The Oncologist
|
July 24, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study
Richard F Riedel, Karla V Ballman, Yao Lu, et al.
Page
of 3